• Login
    • Join
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Formulary
    • Exclusives
    • Top Companies
    • Raw Materials
    • End-User
    • Packaging
    • Directories
    • Events
    • Jobs
    • More
  • Magazine
  • News
  • Formulary
  • Exclusives
  • Top Companies
  • Raw Materials
  • End-User
  • Packaging
  • Directories
  • Events
  • Jobs
  • Current / Back Issues
    Features
    Columns
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    ACI Is Front & Center During the Pandemic

    Sun Care Market Set to Rebound in 2021 as Travel Returns

    Making Up for Lost Time

    All’s Well with Wellness

    Help for Indies
    Online Exclusives
    Association News
    Breaking News
    Financial News
    Industry News
    International
    Marketing News
    New Products
    News Front
    Packaging News
    Patents
    Personnel
    Regulations
    Snapshots
    Top News
    Live From Shows
    Top News
    What You're Reading on Happi.com

    Indie Beauty Innovators Wanted

    Cosmetic Chemists Seek Mentors

    L'Oréal Appoints Two to Executive Committee

    Dr. Sheffield’s Adds New Toothpaste Flavors
    Blog
    Online Exclusives
    Infographics
    Podcasts
    Whitepapers
    Videos
    Expert's Opinion
    HappiTV
    eBook
    Surveys
    International Top 30 Report
    Top 50 Report
    Top Companies
    6. Shiseido

    15. Sun Products

    6. Beiersdorf

    9. AmorePacific

    12. Diversey
    Actives
    Functional Ingredients
    Pigments
    Polymers
    Preservatives
    Surfactants

    The Fragrance Foundation Celebrates Fragrance Day

    China To End Animal Testing for Imported 'Ordinary' Cosmetics

    Inolex Appoints VP Marketing

    Croda International Acquires Alban Muller

    In Pursuit of Perfection
    Air Care/Environmental Fragrance
    AP/Deo
    Color Cosmetics
    Disinfectants
    Fine Fragrance
    Hair Care
    Household Cleaning
    I&I Marketplace
    Laundry Care
    Oral Care
    OTC/Medicated
    Packaging
    Personal Cleansers
    Skin Care
    Sun Care
    Testing

    Indie Beauty Innovators Wanted

    Cosmetic Chemists Seek Mentors

    L'Oréal Appoints Two to Executive Committee

    Pandemic Lifts Cleaning & Personal Care Sales in 2020

    Dr. Sheffield’s Adds New Toothpaste Flavors
    Lab Equipment
    Mixing
    Packaging
    Testing

    Sustainable Cosmetics Summit is Online in June

    A Tube Ready for Prime Time

    Ecovia's Sustainable Cleaning Products Summit Goes Online (March 23-25)

    Burt’s Bees Outlines New Sustainability Goals

    Secret, Old Spice Add Refillable Deo Packaging
    Contract Manufacturing / Private Label Directory
    Buyer's Guide
    Add New Company
    Corporate Profiles
    International Buyers Guide Companies
    LipoTrue Inc.

    Jeen International

    Centerchem Inc

    Praan Naturals

    Siltech Corporation
    Live From Shows
    Meetings
    Webinars
    Snapshots
    • Magazine
      • Current / Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Formulary
    • Directories
      • Buyer's Guide
      • Contract Manufacturing / Private Label Directory
      • Corporate Profiles
      • Add Your Company
    • Raw Materials
      • Actives
      • Functional Ingredients
      • Pigments
      • Polymers
      • Preservatives
      • Surfactants
    • End-User
      • Air Care/Environmental Fragrance
      • AP/Deo
      • Color Cosmetics
      • Disinfectants
      • Fine Fragrance
      • Hair Care
      • Household Cleaning
      • I&I Marketplace
      • Laundry Care
      • Oral Care
      • OTC/Medicated
      • Packaging
      • Personal Cleansers
      • Skin Care
      • Sun Care
      • Testing
    • Packaging
      • Lab Equipment
      • Mixing
      • Packaging
      • Testing
    • Top Companies
      • International Top 30 Report
      • Top 50 Report
    • Online Exclusives
    • Experts Opinion
    • Slideshows
    • HappiTV
    • Videos
    • Podcasts
    • eBook
    • Infographics
    • Blog
    • Whitepapers
    • Surveys
      • R & D Salary Survey
      • Sales & Marketing Salary Survey
    • Job Banks
    • Events
      • Industry Events
      • Live from show Events
      • Webinars
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Safety Assessment In Skin Care

    Testing for Genotoxicity

    ...

    Related CONTENT
    • Krismark Adds Hand Creams
    • New Skin Care Ingredients
    • The Science Behind Beautiful Skin
    • Health Is Wealth
    • Using Data from Studies Conducted by Suppliers
    Nava Dayan, Dr. Nava Dayan LLC03.01.16
    Genotoxicity is defined as the modification of the genetic information in a living cell. It establishes the potential of a compound or mixture to damage the cellular genetic information thereby its likelihood to trigger mutations that may lead to cancer. It can have a direct or indirect effect on DNA, the cell’s genetic material. Cells exposed to a genotoxic environment may act in different manners. If the toxic environment is persistent and cumulative, the cell might opt to “adjust” by changing the expression of its genes. Since many skin care products are intended to be used for long durations and sometimes over large areas of the body, cumulative persistent exposure is a relevant consideration.

    A normal healthy cell will attempt to prevent expression of the genotoxic mutation by either enzymatic DNA repair or by promoting innate programmed cell death termed apoptosis. Apoptosis deletes the cell so healthy functional tissue is maintained. If damage is not corrected, it may lead to mutagenesis. As noted, the alteration of the genetic material can have direct or indirect effects on the DNA; i.e.,  the induction of mutations, mistimed event activation and direct DNA damage leading to mutations. Since the surface of the skin, the stratum corneum, is composed of non-living material (corneocytes and lipids), and since genotoxicity is only applicable to living cells, a genotoxic effect of a topically applied compound will be imparted should the compound penetrate the outer barrier and is able to interact with living skin layers or communicate an effect to the living layers. Therefore, it might be of interest to run a skin absorption study (as described in my March 2015 column).

    A Key Component of Safety
    Genotoxicity should not be confused with mutagenicity. Compounds that are mutagens are genotoxic because they generate genetic changes. However, not all genotoxic compounds are mutagenic. Meaning, a compound can alter the genetic information but not cause mutations.

    The analysis of potential genotoxicity is of key importance in the determination of the relevancy of the assay as part of a tier approach in safety assessment. If the compound’s suggested efficacy mode of action relates to changes in cell genes or proteins, the genotoxicity test may be incorporated in the earlier set of studies and a more comprehensive study package should be generated to exclude such potential toxicity. For example, compounds that are tested and marketed with claims to “repair DNA,” “attenuate cellular death” or “enhance cell viability” should be studied with extra care for this safety endpoint. Changes to the genome at various levels can be a lengthy process and usually are not a result of short time exposure. As noted, since cosmetic products are regularly applied to skin for months and even years, they should be tested for genotoxicity. The genotoxic effect can be to the skin as the exposed organ; and if penetrates through the skin to the circulation – to internal organs as well.

    Metabolic Mechanisms
    Moreover, skin and other organs contain metabolic mechanisms known as Cytochrome P-450. The most intense P-450 in the body is present in the liver, the main metabolic organ; however, skin contains metabolic enzymes as well. This is an orchestrated cassette of proteins, primarily membrane-associated, that metabolize endogenous and exogenous chemicals with the ultimate goal to enable neutralization and excretion out of the body. While the tested compound may not exhibit genotoxic effect, its metabolites may—therefore a valid genotoxicity assay should include evaluating effects from potential metabolites.

    A column about skin metabolism will be published later this year.

    Numerous assays can determine whether a chemical has the potential to induce genetic damage; only a few will be included here. The assays differ in the model utilized, means and times of exposure, tested endpoints and translated implications.


    Endpoints established can include the following:
    • Single-gene mutations.
    • Multilocus mutations, which comprise structural changes to chromosomes such as breaks, deletion, and rearrangement or numerical changes in the genome. The numerical changes to the genome can be aneuploidy (presence of one or a few chromosomes above or below the normal number) and polyploidy (effect on one or more extra sets of chromosomes). 
    • Changes to the DNA; determination of DNA adducts or DNA strand breakages, or measurement of unscheduled DNA synthesis as a cellular response to DNA damage. 
    Since the in vitro assay for genotoxicity can be sensitive, it is imperative that prior to testing, the compound is fully and extensively characterized. If synthetic, the compound should be studied for its level and nature of impurities. If relatively high levels of impurities are present, there is the possibility that the impurities are the cause of positive result and not the actual compound of interest. If the composition tested is of natural origin (such as plant or seed extract) and batch-to-batch consistency presents major variations, the composition should be tested at least for three different lots that represent its composition diversity.

    Popular Assays
    The most widely employed and acknowledged assay to evaluate genotoxicity is the Ames assay, which detects mutagenicity in a bacterial reverse gene mutation test. This test has been shown to detect relevant genetic changes and the majority of genotoxic rodent and human carcinogens. If an Ames test is conducted, the second study in the tier should evaluate the hazard potential to mammalian cells. The Ames test was detailed in the early 1970s by Bruce Ames at the University of California Berkley. It is designed to detect potential mutations in bacteria and serves as a rapid, relatively inexpensive and convenient way to evaluate the mutagenic potential of a compound. The test is performed by incubating a mutated bacterium with the compound of interest, with or without an exogenous metabolic system. The metabolic system, generally a rat liver homogenate (termed “S9 fraction”), is added to evaluate the possible genotoxic effect of metabolites in the system. As previously explained, metabolites are compounds that are formed in the culture as a result of enzymatic conversion. They can potentially be inert; exert activity that is similar to the substrate (which is the tested compound) or toxic. Five or more concentrations of the substance are usually tested and include negative (vehicle) and positive controls with and without metabolic activation. Mutated bacteria, which are capable of producing histidine, will form colonies in the histidine-free media.

    The core principal of the Ames test is the use of amino acid-dependent strains of Salmonella typhimurium and Escherichia coli. Each carries different mutations in various genes in the histidine operon. This means that they cannot produce histidine and will not grow on a histidine deficient media unless they mutate. These mutations act as cores for mutagens that cause DNA damage through various mechanisms. In the absence of an external histidine source, the bacteria cannot grow and form colonies. Therefore only bacteria that have mutated to revert to histidine independence will form colonies. The number of spontaneously induced reverting colonies per plate is relatively constant. When a mutagen is added to the plate, the number of reverting colonies per plate is increased, usually in a dose-related manner. The Ames test cannot be utilized in cases when the test substance is toxic to bacteria such as antibiotics or preservatives. In such case it is recommended that a tier of two tests in mammalian cells is conducted. In addition the fact that this assay uses prokaryotes means that it may not represent human cell behavior. To identify false positive mutagens further tests are required. For example, selected nitrate-containing substances (such as nitroglycerin) can produce false positive results by generating nitric oxide. But not all carcinogens (such as asbestos for example) are mutagens. As a result, the Ames assay may not identify some carcinogens. 

    Conducting Ames Assays
    Ames assays are usually run in two tiers. The initial assay includes five strains of Salmonella typhimurium and one strain of Escherichia coli. Eight to ten dose levels may be tested, as well as vehicle controls, positive mutagens and S9 metabolic activation systems. Triplicate culture per strain or dose is conducted for both test systems to allow statistical generation. The second tier in the assay is perceived as a confirmatory one. Here, the same five strains are tested for at least five dose levels that have been adjusted as determined in the initial assay as well as metabolic activation. The scholars that highlight Ames test limitations point to the fact that it is utilizing bacteria that is very different from human cell and therefore advocate for models using human or mammalian cells.

    Micronucleus Assay
    One established in vitro mammalian cell system for testing mutagenicity is the micronucleus assay. In this assay the presence of chromosomal fragments that appear as small round additions to the nucleus (therefore termed “micronuclei”) are determined in erythrocytes following exposure to the test substance. Mature erythrocytes normally expel their nuclei during development, and thus do not contain DNA. If chromosomal fragments are formed during cell division, they may be retained in the cell and are considered to be a measure of chromosomal damage. The in vitro micronucleus assay has undergone retrospective validation by ECVAM and is described in details in a publication from 2008. ECVAM’s management team concluded that the in vitro micronucleus test is reliable and relevant and can be used as an alternative to the in vitro chromosome aberration test.

    This test detects chromosomal structural aberrations as well as numerical aberrations (both polyploidy and aneuploidy; see prior explanation). A more recent modification of the in vitro micronucleus test is the use of 3D human reconstructed skin models for the assessment of genotoxicity of dermally applied materials. An example for such model, EpiDerm is described in the column on skin irritation published previously (see my September 2015 column).

    In brief, the protocol utilizes various topical doses of the test material exposed for 48 to 72 hours with repeat exposure every 24 hours in the presence of 3µg/ml of Cytochalasin-B in the medium. Cells are harvested from the tissue 24 hours after the last dose as follow:
    • Tissues are washed with DPBS (Dulbecco’s Phosphate-Buffered Saline), followed by EDTA exposure, and then exposed to trypsin-EDTA;
    • Tissues are separated from the membrane and again exposed to trypsin-EDTA;
    • Trypsin-EDTA neutralizing solution is added to the cell suspension before centrifuging;
    • After centrifugation, KCl solution is slowly added to the cells followed by 3ml of cold;
    • MeOH/acetic acid (3:1);
    • The cell suspension is re-centrifuged, the medium removed;
    • 4ml of MeOH/acetic acid is added. The cell suspension is again centrifuged, and the medium removed;
    • The cells are gently placed on the slide immediately; and
    • Slides are stained in acridine orange (AO) solution, rinsed, and then scored using a fluorescent microscope.
    In summary, genotoxicity is a necessary and relevant safety endpoint in the evaluation tier of topically applied compounds and formulations as changes to the cell genome may occur following continuous cumulative exposure to chemicals. Since cosmetic formulations are applied for long duration of time such assessment is important. To determine the scope and priority of genotoxicity in the tier of safety assessment studies, it is recommended to conduct in silico evaluation such as structure-activity relationships; suggested efficacy mode of action and review prior data if it exists. Additional key considerations are molecular weight and lipophilicity for potential skin penetration. Various genotoxicity protocols are now available to conduct in vitro and their applicability should be considered on a case-by-case basis. More than one assay should be conducted and due to Ames test limitations it should not be a standalone study in the tier. 

    Reference
    Mutagenesis vol. 23 no. 4 pp. 271–283, 2008 doi:10.1093/mutage/gen010
    Advance Access Publication 7 March 2008 ECVAM retrospective validation of in vitro micronucleus


    Nava Dayan
    Owner
    Dr. Nava Dayan LLC

    Nava Dayan Ph.D. is the owner of Dr. Nava Dayan L.L.C, a skin science and research consultancy and serving the pharmaceutical, cosmetic, and personal care industries. She has 25 years of experience in the skin care segment, and more than 150 publication credits.
    Tel: 201-206-7341
    E-mail: nava.dayan@verizon.net
    Related Searches
    • media
    • claims
    • management team
    • cosmetic
    Suggested For You
    Krismark Adds Hand Creams Krismark Adds Hand Creams
    New Skin Care Ingredients New Skin Care Ingredients
    The Science Behind Beautiful Skin The Science Behind Beautiful Skin
    Health Is Wealth Health Is Wealth
    Using Data from Studies Conducted by Suppliers Using Data from Studies Conducted by Suppliers
    Advanced Ceramide Technology From Elizabeth Arden Advanced Ceramide Technology From Elizabeth Arden
    Advanced Ceramide Technology from Elizabeth Arden Advanced Ceramide Technology from Elizabeth Arden
    To Tell the Truth? Or Just Tell a Lie? To Tell the Truth? Or Just Tell a Lie?
    There Will Be Blood There Will Be Blood
    Defining Clean Skin Defining Clean Skin
    Selecting In Vitro Test Models:  Monolayers to Skin Explants Selecting In Vitro Test Models: Monolayers to Skin Explants
    The Metabolism of Skin and How To Test It The Metabolism of Skin and How To Test It
    Cell Rejuvenating Intense Care Cell Rejuvenating Intense Care

    Related Safety Assessment In Skin Care

    • Testing

      Selecting In Vitro Test Models: Monolayers to Skin Explants

      ...
      Nava Dayan, Dr. Nava Dayan LLC 11.02.16

    • Actives | Functional Ingredients | Skin Care | Testing

      The Metabolism of Skin and How To Test It

      ...
      Nava Dayan, Dr. Nava Dayan LLC 09.01.16

    • Actives | Functional Ingredients | Skin Care | Testing

      Endocrine Disruption & Cosmetic Ingredients

      ...
      Nava Dayan, Dr. Nava Dayan LLC 07.01.16


    • Testing for Eye Irritation

      Testing for Eye Irritation

      Take a closer look at three test methods.
      Nava Dayan, Dr. Nava Dayan LLC 05.02.16

    • Actives | Functional Ingredients | OTC/Medicated | Polymers | Preservatives | Skin Care | Surfactants | Testing

      Assessment of Potential Skin Sensitization

      Anaphylaxis to skin care products is possible.
      Nava Dayan, Dr. Nava Dayan LLC 01.04.16

    • Test Your Cosmetic Formulas For Photo-Toxicity Reactions

      ...
      Nava Dayan, Dr. Nava Dayan LLC 11.02.15


    • Skin Corrosion & Primary Irritation

      ...
      Nava Dayan, Dr. Nava Dayan LLC 09.01.15

    • Cytotoxicity Is Critical In Cell Culture Study

      ...
      Nava Dayan, Dr. Nava Dayan LLC 07.01.15

    • Solids and Nanoparticles Interactions with Skin

      Solids and Nanoparticles Interactions with Skin

      ...
      Nava Dayan, Dr. Nava Dayan LLC 05.01.15


    • Absorption’s Key Role In Safety Assessment

      ...
      Nava Dayan, Dr. Nava Dayan LLC 03.04.15

    • Actives | Functional Ingredients | OTC/Medicated | Skin Care
      Physical Chemical Properties in Safety Assessment

      Physical Chemical Properties in Safety Assessment

      ...
      Nava Dayan, Dr. Nava Dayan LLC 01.06.15

    Trending
    • Sunscreen On The Spot
    • BASF Achieves Palm Oil Commitment For 2020
    • When The FTC Comes Calling...
    • L'Oréal Appoints Two To Executive Committee
    • Formulating Liquid Laundry Detergents
    Breaking News
    • What You're Reading on Happi.com
    • Indie Beauty Innovators Wanted
    • Cosmetic Chemists Seek Mentors
    • L'Oréal Appoints Two to Executive Committee
    • Dr. Sheffield’s Adds New Toothpaste Flavors
    View Breaking News >
    CURRENT ISSUE

    March 2021

    • ACI Is Front & Center During the Pandemic
    • Rise… Then Shine
    • Making Up for Lost Time
    • All’s Well with Wellness
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Thymoquinone Inhibits Viral Infection in In Vitro Settings, New Study Finds
    IFT Transitions 2021 Annual Event to Digital Experience
    NY Federal Judge Enters Permanent Injunction Against Dietary Supplement Manufacturer
    Coatings World

    Latest Breaking News From Coatings World

    Sherwin-Williams Announces Resignation of President, COO
    Ashland Completes Expansion, Relocation of Viatel Bioresorbable Polymers Manufacturing Facility
    Evonik Receives Sustainability Award from EcoVadis
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Cretex CFO Announces Retirement
    New AI-Based Tool Developed for Coronary Artery Analysis, Intervention Planning
    First Reported Use of Pulse Biosciences' CellFX System
    Contract Pharma

    Latest Breaking News From Contract Pharma

    AGC Biologics Expands Cell and Gene Facility in Italy
    Celonic to Boost Cell & Gene Therapy Production
    Pharmaron Acquires Biomanufacturing Site in the UK from AbbVie
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Ulta Beauty Opens in Herald Square
    Elizabeth Arden Taps Sui He as Global Brand Ambassador
    Natura &Co Outperforms the Global Market in Q4 2020
    Happi

    Latest Breaking News From Happi

    What You're Reading on Happi.com
    Indie Beauty Innovators Wanted
    Cosmetic Chemists Seek Mentors
    Ink World

    Latest Breaking News From Ink World

    Massilly North America Adds Koenig & Bauer MetalStar 3 Metal Decorating Press
    Hydrocarbon Solvents Market to Surpass $8.1 Billion by 2030
    Access Direct Mail Doubles Revenue with SCREEN's Truepress Jet520HD
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Arjobex America welcomes Maggie Naberezny to sales team
    Henkel publishes 30th Sustainability Report
    Avery Dennison Smartrac launches new Circus Pro inlays
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    FPInnovations Develops Biodegradable Mask
    Sani Professional Sanitizing and Disinfecting Products Approved by EPA
    Autefa Solutions Offers Fully Automated Line for Protective Mask Production
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Colfax Decides to Divide Its Businesses
    Stryker Corp.'s 2020 Sales Slip 3.6 Percent
    Bioventus Appoints Managing Director, China and Asia Pacific
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Comercial Kywi Improves Customer Service, Front-Store Operations with Zebra Mobile Solution
    Global Smart Glass Market to Register 6.8% CAGR Between 2021-28: Grand View Research
    Global Printed Circuit Board Market Projected to Reach $69.32 Billion by 2027

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login